• 1
    Starzl TE, Iwatsuki S, Shaw BW Jr, Gordon RD, Esquivel CO. Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis 1985; 5: 334343.
  • 2
    European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423428.
  • 3
    The US Multicentre FK506 Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 11101115.
  • 4
    Siekierka JJ, Sigal NH. FK-506 and cyclosporin A: Immunosuppressive mechanism of action and beyond. Curr Opin Immunol 1992; 4: 548552.
  • 5
    O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A, The UK and Republic of Ireland Liver Transplant Study Group. Tacrolimus versus microemulsified ciclosporin in liver transplantation: The TMC randomised controlled trial. Lancet 2002; 360: 11191125.
  • 6
    Knoll GA, Bell RC, Knoll GA, Bell RC. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ 1999; 318: 11041107.
  • 7
    Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810821.
  • 8
    Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. In: Cochrane Database of Systematic Reviews 2005, Issue 1 CD005161.
  • 9
    Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 982989.
  • 10
    Arnold JC, Theilmann L. Vergleich zwischen Tacrolimus (FK 506) und Cyclosporin in der immunosuppressiven Therapie nach Lebertransplantation [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. Zeitschrift fur Gastroenterologie 1995; 33: 624625.
  • 11
    Loinaz C, Marin LM, Gonzalez-Pinto I, Gomez R, Jimenez C, Moreno E. A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 ransomized liver transplant recipients: Midterm efficacy and safety. Transplant Proc 2001; 33: 34393441.
  • 12
    Ericzon B, Eusufzai S, Soderdahl G, Duraj F, Einarsson K, Angelin B. Secretion and composition of bile after human liver transplantation. Transplantation 1997; 63: 7480.
  • 13
    Trull A, Hughes V, Cooper D et al. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. Liver Transpl 2002; 8: 224232.
  • 14
    Timmermann W, Erhard J, Lange R et al. A randomised trial comparing the efficacy and safety of tacrolimus with microemulsified cyclosporine after liver transplantation. Transplant Proc 2002; 34: 15161518.
  • 15
    Stegall M, Wachs ME, Everson G et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: A prospective trial of cyclosporine and tacrolimus. Transplantation 1997; 64: 17551760.
  • 16
    Fisher RA, Ham JM, Marcos A et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic transplantation. Transplantation 1998; 66: 16161621.
  • 17
    Fung J, Abu-Elmagd K, Jain A et al. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc 1991; 23: 29772983.
  • 18
    Grazi GL, Levy G, Wu Y et al. 12-month follow-up data from a randomized multicentre, prospective study of cyclosporine C2 monitoring versus tacrolimus in liver transplantation (LIS2T). Am J Transplant 2004; 4 (Suppl 8): 268.
  • 19
    Greig P, Lilly L, Scudamore C et al. Early steroid withdrawal after liver transplantation: The Canadian tacrolimus versus microemulsion cyclosporin a trial: 1-year follow-up. Liver Transpl 2003; 9: 587595.
  • 20
    Klupp J, Glanemann M, Bechstein WO et al. Mycophenolate mofetil in combination with tacrolimus versus neoral after liver transplantation. Transplant Proc 1999; 31: 11131114.
  • 21
    Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (neoral) and tacrolimus. Liver Transpl 2002; 8: 690700.
  • 22
    Kelly D, Jara P, Rodeck B et al. Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: Randomised European multicentre trial. Lancet 2004; 364: 10541061.
  • 23
    Martin P, Busuttil RW, Goldstein RM et al. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective randomized trial. Liver Transpl 2004; 10: 12581262.
  • 24
    Muhlbacher F. European Liver Transplantation Tacrolimus vs Cyclosporin Microemulsion Study Group. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. Transpl Proc 2001; 33: 13391340.
  • 25
    Rolles K, Davidson BR, Burroughs AK. A pilot study of immunosuppressive monotherapy in liver transplantation: Tacrolimus versus microemulsified cyclosporin. Transplantation 1999; 68: 11951209.
  • 26
    Zervos XA, Weppler D, Fragulidis GP et al. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. Transplantation 1998; 65: 10441046.
  • 27
    Fung JJ, Eliasziw M, Todo S et al. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg 1996; 183: 117125.
  • 28
    Fisher RA, Stone JJ, Wolfe LG et al. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation. Clin Transplant 2004; 18: 463472.
  • 29
    Muehlbacher FF. for the European Liver Transplantation Tacrolimus vs Cyclosporin Microemulsion Study Group. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of one-year follow-up. In: 10th ESOT & 12th ETCO Congress 2001, October 6–11, 2001, Lisboa , Portugal . 2001.
  • 30
    Levy G, Villamil F, Samuel D et al. LIS2T Study Group. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation 2004; 77: 16321638.
  • 31
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 15391558.
  • 32
    Starzl TE, Donner A, Eliasziw M et al. Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet 1995; 346: 13461350.